Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2003;42:457-458
Published online before print August 25, 2003, doi: 10.1161/01.HYP.0000091272.24311.EF
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
42/4/457    most recent
01.HYP.0000091272.24311.EFv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Egan, B. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Egan, B. M.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Dietary Sodium
*Diets
*High Blood Pressure
Related Collections
Right arrow Health policy and outcome research
Right arrow Other hypertension
Right arrow Clinical Studies

(Hypertension. 2003;42:457.)
© 2003 American Heart Association, Inc.


Editorial Commentary

Reproducibility of BP Responses to Changes in Dietary Salt

Compelling Evidence for Universal Sodium Restriction?

Brent M. Egan

From the Medical University of South Carolina, Charleston.

Correspondence to Brent M. Egan, MD, Medical University of South Carolina, 96 Jonathan Lucas Street, CSB 826H, Charleston, SC 29425. E-mail eganbm@musc.edu


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Hypertension is a highly prevalent disorder association with significant population-attributable risk for cardiovascular and renal morbidity and mortality. Given the high lifetime risk of hypertension and associated complications, a public health approach to prevention is logical. The DASH-Sodium trial represents a landmark study on nutrition and blood pressure (BP) regulation in a middle-aged population ({approx}48±10 years) comprised of overweight-obese (body mass index [BMI] {approx}30±5 kg/m2), disproportionately minority ({approx}60%, mainly African American) volunteers with BP averaging in the high normal range at {approx}134±10/{approx}86±5 mm Hg.1 The findings from this carefully controlled feeding study, if applied to the general population, have the potential to reduce BP and delay and possibly prevent the development of hypertension and associated complications.

Based on a post hoc analysis on the reproducibility of salt sensitivity in the DASH-Sodium trial, Obarzanek and colleagues2 conclude that salt sensitivity is not a highly reproducible finding. The authors interpret the low-order reproducibility of BP responses to changes of dietary sodium (r=0.27, r2=0.07) as further support for universal Na+ restriction in the entire population. They extend this reasoning to a recommendation for limiting sodium intake in food processing.

Obarzanek et al, acknowledge that this is a post hoc analysis of the DASH-Sodium data for which the study was not designed. In this regard, there are 3 significant limitations.




This article has been cited by other articles:


Home page
J. Am. Coll. Nutr.Home page
A. G. Logan
Dietary Sodium Intake and Its Relation to Human Health: A Summary of the Evidence
J. Am. Coll. Nutr., June 1, 2006; 25(3): 165 - 169.
[Full Text] [PDF]


Home page
HypertensionHome page
D. W. Jones
Dietary Sodium and Blood Pressure
Hypertension, May 1, 2004; 43(5): 932 - 935.
[Full Text] [PDF]


Home page
HypertensionHome page
F. J. He, G. A. MacGregor, and B. M. Egan
Universal Salt Reduction * Response
Hypertension, March 1, 2004; 43(3): e12 - e13.
[Full Text] [PDF]